ACHV
Price
$2.33
Change
-$0.02 (-0.85%)
Updated
Apr 28, 02:15 PM (EDT)
Capitalization
81.86M
10 days until earnings call
SIGY
Price
$3.53
Change
-$0.62 (-14.94%)
Updated
Apr 25 closing price
Capitalization
5.67M
Ad is loading...

ACHV vs SIGY

Header iconACHV vs SIGY Comparison
Open Charts ACHV vs SIGYBanner chart's image
Achieve Life Sciences
Price$2.33
Change-$0.02 (-0.85%)
Volume$100
Capitalization81.86M
Sigyn Therapeutics
Price$3.53
Change-$0.62 (-14.94%)
Volume$300
Capitalization5.67M
ACHV vs SIGY Comparison Chart
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHV vs. SIGY commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a StrongBuy and SIGY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (ACHV: $2.36 vs. SIGY: $3.53)
Brand notoriety: ACHV and SIGY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 138% vs. SIGY: 101%
Market capitalization -- ACHV: $81.86M vs. SIGY: $5.67M
ACHV [@Biotechnology] is valued at $81.86M. SIGY’s [@Biotechnology] market capitalization is $5.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileSIGY’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • SIGY’s FA Score: 0 green, 5 red.
According to our system of comparison, SIGY is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 5 TA indicator(s) are bullish.

  • ACHV’s TA Score: 5 bullish, 3 bearish.

Price Growth

ACHV (@Biotechnology) experienced а +18.59% price change this week, while SIGY (@Biotechnology) price change was -14.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

Reported Earning Dates

ACHV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHV($81.9M) has a higher market cap than SIGY($5.67M). SIGY YTD gains are higher at: 12.063 vs. ACHV (-32.955). SIGY has higher annual earnings (EBITDA): -2.65M vs. ACHV (-37.42M). ACHV has more cash in the bank: 34.3M vs. SIGY (165K). SIGY has less debt than ACHV: SIGY (1.93M) vs ACHV (9.96M). ACHV (0) and SIGY (0) have equivalent revenues.
ACHVSIGYACHV / SIGY
Capitalization81.9M5.67M1,445%
EBITDA-37.42M-2.65M1,411%
Gain YTD-32.95512.063-273%
P/E RatioN/AN/A-
Revenue00-
Total Cash34.3M165K20,788%
Total Debt9.96M1.93M515%
FUNDAMENTALS RATINGS
ACHV vs SIGY: Fundamental Ratings
ACHV
SIGY
OUTLOOK RATING
1..100
6350
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9063
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (50) in the Biotechnology industry is in the same range as SIGY (50) in the null industry. This means that ACHV’s stock grew similarly to SIGY’s over the last 12 months.

ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SIGY (100) in the null industry. This means that ACHV’s stock grew similarly to SIGY’s over the last 12 months.

ACHV's SMR Rating (99) in the Biotechnology industry is in the same range as SIGY (100) in the null industry. This means that ACHV’s stock grew similarly to SIGY’s over the last 12 months.

SIGY's Price Growth Rating (63) in the null industry is in the same range as ACHV (90) in the Biotechnology industry. This means that SIGY’s stock grew similarly to ACHV’s over the last 12 months.

SIGY's P/E Growth Rating (98) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that SIGY’s stock grew similarly to ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHV
RSI
ODDS (%)
Bullish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bullish Trend 4 days ago
73%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Ad is loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ILIKF0.550.01
+2.09%
Ilika PLC.
ENGIY21.640.08
+0.37%
ENGIE SA
GNGBY19.030.01
+0.03%
Getinge AB
XOS3.88-0.03
-0.77%
Xos
EDNMY15.00-3.50
-18.92%
Edenred Malakoff

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ERAS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-1.67%
ERAS - ACHV
41%
Loosely correlated
-0.71%
ABOS - ACHV
40%
Loosely correlated
-1.82%
ATOS - ACHV
40%
Loosely correlated
+3.22%
ELVN - ACHV
39%
Loosely correlated
-0.49%
AXSM - ACHV
38%
Loosely correlated
+0.82%
More

SIGY and

Correlation & Price change

A.I.dvisor tells us that SIGY and OTLK have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGY and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGY
1D Price
Change %
SIGY100%
-14.94%
OTLK - SIGY
23%
Poorly correlated
-1.29%
ACHV - SIGY
21%
Poorly correlated
-1.67%
KALA - SIGY
21%
Poorly correlated
-3.64%
CSPHF - SIGY
8%
Poorly correlated
N/A
CPMV - SIGY
6%
Poorly correlated
N/A
More